Venous Access Devices Market Share

North American Market Forecasts

The venous access devices market in the North America region is set to hold the largest revenue share of 35% by the end of 2036. The USA and Canada are projected to have the largest shares, thus dominating the market. This can be accounted on the back of growing cases of chronic diseases including health concerns such as diabetes, kidney failure, and multiple sclerosis owing to this the regional market is anticipated to register substantial growth. In particular, the Abre vein self-expanding device was innovated and authorized by the Food and Drug Administration in 2020 in the United States

European Market Statistics

The market in the Europe region is set to grow notably by the end of the forecast period. A major increase in the production of generic drugs by various drug companies is expected to meet the need for delivery technology. This has resulted in a large product pipeline and higher returns for existing products, which is an important factor behind the sector's growth. According to press reports, catheters are soft tubes inserted into the largest vein near the heart of the patient.

Frequently Asked Questions (FAQ)

The growing prevalence of chronic disease and growing technological advancement are some of the major factors anticipated to drive the growth of the venous access devices market.

The market is anticipated to attain a CAGR of ~6% over the forecast period, i.e., 2024-2036.

The major players in the market are of Baxter International, C R Bard, Reinventing Venous Access, Becton Dickinson and Company, Boston Scientific Corporation, Teleflex Incorporated., and others.

The hospital segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in North America is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.

Venous Access Devices Market Share